Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Cited by CrossRef (16)

  1. Luca Mazzoni, Francesca Giampieri, Jose Miguel Alvarez Suarez, Massimiliano Gasparrini, Bruno Mezzetti, Tamara Yuliett Forbes Hernandez, Maurizio Antonio Battino. Isolation of strawberry anthocyanin-rich fractions and their mechanisms of action against murine breast cancer cell lines. Food Funct. 2019
    https://doi.org/10.1039/C9FO01721F
  2. Choongho Lee. Therapeutic Modulation of Virus-Induced Oxidative Stress via the Nrf2-Dependent Antioxidative Pathway. Oxidative Medicine and Cellular Longevity 2018;2018:1
    https://doi.org/10.1155/2018/6208067
  3. Sang Kang, Sunmi Lee, Joanna Lee. Cancer-Associated Function of 2-Cys Peroxiredoxin Subtypes as a Survival Gatekeeper. Antioxidants 2018;7:161
    https://doi.org/10.3390/antiox7110161
  4. Liang Liu, Zhichen Zhao, Qimeng Yin, Xiaolu Zhang. TTB Protects Astrocytes Against Oxygen-Glucose Deprivation/Reoxygenation-Induced Injury via Activation of Nrf2/HO-1 Signaling Pathway. Front. Pharmacol. 2019;10
    https://doi.org/10.3389/fphar.2019.00792
  5. Pawel Bialk, Yichen Wang, Kelly Banas, Eric B. Kmiec. Functional Gene Knockout of NRF2 Increases Chemosensitivity of Human Lung Cancer A549 Cells In Vitro and in a Xenograft Mouse Model. Molecular Therapy - Oncolytics 2018;11:75
    https://doi.org/10.1016/j.omto.2018.10.002
  6. Kyoung Ah Kang, Mei Jing Piao, Yu Jae Hyun, Ao Xuan Zhen, Suk Ju Cho, Mee Jung Ahn, Joo Mi Yi, Jin Won Hyun. Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells. Exp Mol Med 2019;51
    https://doi.org/10.1038/s12276-019-0238-y
  7. Wei Chen, Xi-Yuan Chen, Ying Wang, Hai-Ying Wang, Wen-Jing Zhou, Tian Yu. Mechanism of Emulsified Isoflurane Postconditioning–Induced Activation of the Nrf2–Antioxidant Response Element Signaling Pathway During Myocardial Ischemia-Reperfusion. Journal of Cardiovascular Pharmacology 2019;73:265
    https://doi.org/10.1097/FJC.0000000000000668
  8. Simona Pompili, Roberta Sferra, Eugenio Gaudio, Angelo Viscido, Giuseppe Frieri, Antonella Vetuschi, Giovanni Latella. Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?. IJMS 2019;20:4061
    https://doi.org/10.3390/ijms20164061
  9. Indu Khatri, Koelina Ganguly, Sunandini Sharma, Joseph Carmicheal, Sukhwinder Kaur, Surinder K. Batra, Manoj K. Bhasin. Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. Sci Rep 2019;9
    https://doi.org/10.1038/s41598-018-36328-w
  10. Alfredo Briones-Herrera, Dianelena Eugenio-Pérez, Jazmin Gabriela Reyes-Ocampo, Susana Rivera-Mancía, José Pedraza-Chaverri. New highlights on the health-improving effects of sulforaphane. Food Funct. 2018;9:2589
    https://doi.org/10.1039/C8FO00018B
  11. Pelin Telkoparan-Akillilar, Sibel Suzen, Luciano Saso. Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs. IJMS 2019;20:2025
    https://doi.org/10.3390/ijms20082025
  12. Yoojin Noh, Sang‐Min Jeon, Sooyoung Shin. Association between glucose‐lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy. Int. J. Cancer 2019;144:1530
    https://doi.org/10.1002/ijc.31870
  13. Bo Zhang, Zhiyuan Ma, Biqin Tan, Nengming Lin. Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung. Expert Opinion on Therapeutic Targets 2019;23:241
    https://doi.org/10.1080/14728222.2019.1559824
  14. Xiangcui Chen, Qipeng Wu, Yueming Chen, Jiahao Zhang, Huachao Li, Zhicheng Yang, Yang Yang, Yanchao Deng, Luyong Zhang, Bing Liu. Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of paclitaxel in non‐small cell lung cancer cells via Nrf2 inhibition. Br J Pharmacol 2019;176:2079
    https://doi.org/10.1111/bph.14652
  15. Soo-Youl Kim. Cancer Metabolism: a Hope for Curing Cancer. Biomolecules & Therapeutics 2018;26:1
    https://doi.org/10.4062/biomolther.2017.300
  16. Emiliano Panieri, Luciano Saso. Potential Applications of NRF2 Inhibitors in Cancer Therapy. Oxidative Medicine and Cellular Longevity 2019;2019:1
    https://doi.org/10.1155/2019/8592348